Adherence to Polypharmacy in Patients With Opioid Substitution Therapy Using Electronics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2016-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Electronic dispensers for polypharmacy are used in home care to assist patients with their medication management and to improve adherence. Opioid dependent patients with substitution therapy often exhibit multiple risk factors for non-adherence. The increase of both the age and associated comorbidities in this population demand for innovative solutions to optimize medication management. The investigators developed a novel medication supply model with an automated electronic medication dispenser to simultaneously assist opioid dependent patients with their medication and objectively monitor their adherence. This study aims to demonstrate the feasibility of the new supply model.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults

NCT01430702

Medication Adherence Medication Nonadherence Adverse Reaction to Drug

WITHDRAWN NA

Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)

NCT06655337

Acute Disease Acute Hospitalization Coughing +7 more

RECRUITING NA

Tailored Medication Management Intervention

NCT04717297

Medication Non Adherence Polypharmacy

COMPLETED NA

Electronic Medication Adherence Reporting and Feedback During Care Transitions

NCT03475030

Medication Adherence

COMPLETED NA

The eDosette Pilot Study

NCT03513224

Medication Adherence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance-Related Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

electronic medication dispenser

An Automatic Tablet Dispensing and Packaging System is used to repack all solid oral prescription medications for each participant into unit-of-dose pouches. Every participant receives a roll with pouches for 14-28 days loaded into a dispenser installed at their homes. The electronic medication dispenser is a remote controlled, electronic medication management aid reminding the patients with acoustic alerts to take their medication.

Group Type EXPERIMENTAL

electronic medication dispenser (medido)

Intervention Type DEVICE

Automated dispense of medication through an electronic dispenser

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electronic medication dispenser (medido)

Automated dispense of medication through an electronic dispenser

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

medido

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* written informed consent given
* reading and writing skills in German
* Stable housing situation in the canton of Basel-City and adjacent communities
* Accessibility by phone
* Minimum duration in opioid substitution treatment for 2 months
* Polypharmacy (\> 3 solid oral medications)
* Routine monitoring of clinical parameters less than 1 week before inclusion or agreed within 1 week from inclusion
* Insured with Swiss health insurance